Stay updated on Incyte Press Releases
Sign up to get notified when there's something new on the Incyte Press Releases page.
Latest updates to the Incyte Press Releases page
- CheckyesterdayChange DetectedThe page has removed a significant announcement regarding the FDA approval of Zynyz® for advanced anal cancer, while adding a report about an inducement grant by Incyte.SummaryDifference17%
- Check8 days agoChange DetectedIncyte has appointed Bill Meury as the new Chief Executive Officer, succeeding Hervé Hoppenot, who is set to retire.SummaryDifference11%
- Check15 days agoChange DetectedThe webpage has been updated with new FDA approvals and collaborations related to Incyte's products, while several previous updates and financial results have been removed.SummaryDifference100%
- Check22 days agoChange DetectedThe page has added a significant publication date for Phase 3 data on Incyte’s Retifanlimab in a specific cancer type, while removing a previous announcement about financial results.SummaryDifference100%
- Check29 days agoChange DetectedThe page has updated its content to include new announcements regarding Incyte's mutCALR-Directed Monoclonal Antibody, while removing previous information about positive results from clinical trials of Povorcitinib.SummaryDifference22%
- Check36 days agoChange DetectedThe page has been updated to include an upcoming investor conference presentation by Incyte, while the announcement of the results from a previous clinical trial has been removed.SummaryDifference19%
Stay in the know with updates to Incyte Press Releases
Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.